Vulgaroo

Vulgaroo was founded in 2022 in Bordeaux, France, by 2 co-founders with complementary skills (tech/AI + business). It has developed its technology for 2 years, has filed patents, has proven its effectiveness within a POC with medical centers and physicians in 2023. The technology is hosted in servers with all the certifications required to manage securely healh data. It has been co-developed with physicians and with patients. Vulgaroo has signed several partnerships with universities in France and in Europe. And with patients advocacy groups, to have patients involved in the design and the validation of the technology. Vulgaroo is now finalizing its MVP and plans to go live in summer 2024 for its first clients, with a focus in oncology. Vulgaroo's first revenues are expected in S2 2024, and break even is planned for 2027. The company is now raising funds with early stage investors to be the leader of medical reports simplification in the Pathology labs market first.